Literature DB >> 30713404

CHADS-VASc Score in STEMI Patients: Should We Use It Really?

Metin Okşul1, Yusuf Ziya Şener1, Cem Çöteli1.   

Abstract

Entities:  

Year:  2019        PMID： 30713404      PMCID： PMC6342841          DOI： 10.6515/ACS.201901_35(1).20180124A

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN： 1011-6842            Impact factor:   2.672


× No keyword cloud information.
  5 in total

1.  Renal function on admission affects both treatment strategy and long-term outcomes of patients with myocardial infarction (from the Polish Registry of Acute Coronary Syndromes).

Authors:  Michał Hawranek; Marek Gierlotka; Mariusz Gąsior; Bartosz Hudzik; Piotr Desperak; Aneta Ciślak; Mateusz Tajstra; Tadeusz Osadnik; Piotr Rozentryt; Lech Poloński
Journal:  Kardiol Pol       Date:  2017-02-02       Impact factor: 3.108

Review 2.  Prognostic value of glycated hemoglobin among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis.

Authors:  Guangxiao Li; Xiaowen Hou; Ying Li; Peng Zhang; Qiongrui Zhao; Juan Li; Jingpu Shi
Journal:  Clin Chem Lab Med       Date:  2017-07-26       Impact factor: 3.694

3.  Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study.

Authors:  Walid Saliba; Naomi Gronich; Ofra Barnett-Griness; Gad Rennert
Journal:  Am J Med       Date:  2016-03-21       Impact factor: 4.965

4.  The Value of CHA2DS2VASC Score in Predicting All-Cause Mortality in Patients with ST-Segment Elevation Myocardial Infarction Who Have Undergone Primary Percutaneous Coronary Intervention.

Authors:  Kudret Keskin; Süleyman Sezai Yıldız; Gökhan Çetinkal; Gökhan Aksan; Hakan Kilci; Şükrü Çetin; Serhat Sığırcı; Kadriye Kılıçkesmez
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

5.  Anemia: A significant cardiovascular mortality risk after ST-segment elevation myocardial infarction complicated by the comorbidities of hypertension and kidney disease.

Authors:  Wei-Chieh Lee; Hsiu-Yu Fang; Huang-Chung Chen; Chien-Jen Chen; Cheng-Hsu Yang; Chi-Ling Hang; Chiung-Jen Wu; Chih-Yuan Fang
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.